top of page

Scientific studies on mRNA

Pericarditis after administration of the BNT162b2 mRNA vaccine COVID-19

Cardiac

Pericarditis with Increased Vascular Permeability after COVID-19 Vaccination

Cardiac

Perimyocarditis Following COVID-19 Vaccination

Cardiac

Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male, a case report

Cardiac

Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine Journal of the Pediatric Infectious Diseases Society Oxford Academic

Cardiac

Perimyocarditis in teens

Cardiac

Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents

Cardiac

Possible Association Between COVID-19 Vaccine and Myocarditis

Cardiac

Post-COVID mRNA vaccine myocarditis in children, report of two cases

Cardiac

Post-mRNA COVID-19 Vaccination Myocarditis

Cardiac

Post-RNA (mRNA) Vaccination Myocarditis, CMR Features

Cardiac

Post-vaccine COVID-19 acute myocarditis, case reports and literature review

Cardiac

Prominent J Waves and Ventricular Fibrillation Caused by Myocarditis and Pericarditis After BNT162b2 mRNA COVID-19 Vaccination

Cardiac

Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis

Cardiac

Rapid resolution of severe pericardial effusion using anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse, a case report

Cardiac

Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent

Cardiac

Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent

Cardiac

Recurrent Kounis syndrome - a life-threatening event after COVID-19 vaccine administration

Cardiac

Recurrent MRI-Documented Myocarditis Following Pfizer-BioNTech SARS-CoV-2 Vaccinatio

Cardiac

Recurrent Myocarditis Following COVID-19 Infection and the mRNA Vaccine

Cardiac
bottom of page